Last reviewed · How we verify
Nasal packing Dexmedetomidine
At a glance
| Generic name | Nasal packing Dexmedetomidine |
|---|---|
| Sponsor | Kafrelsheikh University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study (NA)
- Comparative Study Between the Effect of Dexmedetomidine ,Midazolam or Bupivacaine Packing During FESS on Surgical Field Visualization (PHASE3)
- Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nasal packing Dexmedetomidine CI brief — competitive landscape report
- Nasal packing Dexmedetomidine updates RSS · CI watch RSS
- Kafrelsheikh University portfolio CI